Search alternatives:
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), teer decrease (Expand Search)
significantly increased » significant increase (Expand Search)
increased decrease » increased release (Expand Search), increased crash (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
level decrease » levels decreased (Expand Search), level increased (Expand Search), teer decrease (Expand Search)
-
1241
Blood concentrations of VEGF-A121, VEGF-A165, and VEGF-A pre- and post-bevacizumab administration.
Published 2024Subjects: -
1242
-
1243
-
1244
-
1245
Percentage distribution of maternal deaths by cause of death, PDHS 2007 and PMMS 2019.
Published 2025Subjects: -
1246
Maternal mortality ratio (MMR) by cause of death, per 100,000 live births, PDHS 2007 and PMMS 2019.
Published 2025Subjects: -
1247
-
1248
-
1249
-
1250
-
1251
MMR (maternal deaths per 100,000 live births) and 95% confidence limits, PDHS 2007 and PMMS 2019.
Published 2025Subjects: -
1252
-
1253
-
1254
-
1255
-
1256
-
1257
Alterations in hematological parameters induced by dimethoate after 90 days.
Published 2025Subjects: -
1258
-
1259
Alterations in hematological parameters induced by dimethoate after 60 days.
Published 2025Subjects: -
1260
Alterations in hematological parameters induced by dimethoate after 30 days.
Published 2025Subjects: